Form D · Biotechnology
Talon Therapeutics, Inc.
San Mateo, CA · CIK 0001140028
Offering snapshot reported Jan 13, 2012 · SEC filing
- Reported sold
- $258K Offering amount: $2.29M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 9, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 13, 2012 | Initial | $258,000 | No comparison | 2 | SEC filing |
| Jan 13, 2012 | Initial | $10,315,800 | No comparison | 4 | SEC filing |
| Nov 8, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 9, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-171877
Source: Form D, filed Jan 13, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Craig W. Carlson | Executive |
| Steven R. Deitcher, M.D. | Director, Executive |
| Andrew Ferrer | Director |
| Howard P. Furst, M.D. | Director |
| Samir M. Gharib | Executive |
| Cecilia Gonzalo | Director |
| Jonathan Leff | Director |
| Paul V. Maier | Director |
| Leon E. Rosenberg, M.D. | Director |
| Robert J. Spiegel | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2207 Bridgepointe Parkway Suite 250
San Mateo, CA, 94404
San Mateo, CA, 94404